MedTrace Logo

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

NCT07223463 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2025-10-31

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a tailored intervention can help make it easier for adolescents and young adults with cancer to take their medications. The main questions the researchers are trying to answer are:

* Does the tailored intervention increase adherence?
* Does the tailored intervention improve quality of life?
* Does the tailored intervention reduce health care utilization?

The researchers will compare the tailored intervention to a uniform standard of care intervention (an intervention designed to be similar to what is currently happening in clinical care) to see if the tailored intervention works to improve adherence.

Participants will:

* Use an electronic pill bottle or box to store their medication
* Participate in intervention sessions
* Complete surveys before the intervention, after the intervention, and 6-months later

Conditions

Interventions

BEHAVIORAL

Tailored Program

Participants will participate in 4 sessions with a coach, 1 every other week. During these sessions, the participant will work with their coach to identify a barrier to adherence they would like to target. Then, they will work with their coach to create an action plan using evidence-based behavior change techniques to address this barrier. In between sessions (on alternating weeks), the coach will check-in with a text reminder about the plan.

BEHAVIORAL

Feedback Program (Uniform Standard of Care)

Participants will receive weekly text messages with feedback about their adherence and guidance for requesting additional support if desired

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Seattle Children's Hospital

    collaborator OTHER

  • University of Kansas Medical Center

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Meghan E. McGrady, PhD · Children's Hospital Medical Center, Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2030-01-31
Completion
2030-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07223463 on ClinicalTrials.gov